PMID- 26983947
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20190202
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 6
IP  - 3
DP  - 2016 Mar 16
TI  - Role of community pharmacists in the use of antipsychotics for behavioural and 
      psychological symptoms of dementia (BPSD): a qualitative study.
PG  - e010278
LID - 10.1136/bmjopen-2015-010278 [doi]
LID - e010278
AB  - OBJECTIVE: This study aimed to use qualitative methodology to understand the 
      current role of community pharmacists in limiting the use of antipsychotics 
      prescribed inappropriately for behavioural and psychological symptoms of 
      dementia. DESIGN: A qualitative study employing focus groups was conducted. Data 
      were analysed using thematic analysis. SETTING: 3 different geographical 
      locations in the England. PARTICIPANTS: Community pharmacists (n=22). RESULTS: 
      The focus groups identified an array of factors and constraints, which affect the 
      ability of community pharmacists to contribute to initiatives to limit the use of 
      antipsychotics. 3 key themes were revealed: (1) politics and the medical 
      hierarchy, which created communication barriers; (2) how resources and remit 
      impact the effectiveness of community pharmacy; and (3) understanding the nature 
      of the treatment of dementia. CONCLUSIONS: Our findings suggest that an 
      improvement in communication between community pharmacists and healthcare 
      professionals, especially general practitioners (GPs) must occur in order for 
      community pharmacists to assist in limiting the use of antipsychotics in people 
      with dementia. Additionally, extra training in working with people with dementia 
      is required. Thus, an intervention which involves appropriately trained 
      pharmacists working in collaboration with GPs and other caregivers is required. 
      Overall, within the current environment, community pharmacists question the 
      extent to which they can contribute in helping to reduce the prescription of 
      antipsychotics.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not 
      already granted under a licence) please go to 
      http://www.bmj.com/company/products-services/rights-and-licensing/
FAU - Maidment, Ian D
AU  - Maidment ID
AUID- ORCID: 0000-0003-4152-9704
AD  - School of Life and Health Sciences, Aston Research Centre for Healthy Ageing 
      (ARCHA), Aston University, Birmingham, UK.
FAU - Aston, Lydia
AU  - Aston L
AD  - School of Life and Health Sciences, Aston University, Birmingham, UK.
FAU - Hilton, Andrea
AU  - Hilton A
AD  - Faculty of Health and Social Care, University of Hull, Hull, UK.
FAU - Iqbal, Naveed
AU  - Iqbal N
AD  - Department of Pharmacy, School of Life and Health Sciences, Aston University, 
      Birmingham, UK.
FAU - Child, Anne
AU  - Child A
AD  - Avante Care, Faversham, Kent, UK.
FAU - Shaw, Rachel
AU  - Shaw R
AD  - School of Life and Health Sciences, Aston University, Birmingham, UK.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20160316
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
RN  - 0 (Antipsychotic Agents)
SB  - IM
MH  - Antipsychotic Agents/*therapeutic use
MH  - *Communication
MH  - Community Pharmacy Services/*standards
MH  - Cooperative Behavior
MH  - Dementia/*drug therapy
MH  - England
MH  - Female
MH  - Focus Groups
MH  - General Practitioners
MH  - Humans
MH  - Male
MH  - Pharmacies/*organization & administration
MH  - *Pharmacists
MH  - Qualitative Research
PMC - PMC4800147
OTO - NOTNLM
OT  - CLINICAL PHARMACOLOGY
OT  - QUALITATIVE RESEARCH
EDAT- 2016/03/18 06:00
MHDA- 2016/12/15 06:00
PMCR- 2016/03/16
CRDT- 2016/03/18 06:00
PHST- 2016/03/18 06:00 [entrez]
PHST- 2016/03/18 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
PHST- 2016/03/16 00:00 [pmc-release]
AID - bmjopen-2015-010278 [pii]
AID - 10.1136/bmjopen-2015-010278 [doi]
PST - epublish
SO  - BMJ Open. 2016 Mar 16;6(3):e010278. doi: 10.1136/bmjopen-2015-010278.